Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe record history now shows Revision: v3.6.6, replacing the previous v3.6.5. This is a metadata/build label update in the study history display and does not alter the study content or functionality.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe history now includes a new revision entry (v3.6.5) and the References section along with the prior revision entry (v3.6.4) were removed, reflecting an update to the historical log.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry (v3.6.4) was added to the history, replacing the previous v3.6.3. This represents a minor backend or UI update to the page metadata and does not modify study details.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record history now shows Revision: v3.6.3, replacing v3.6.2, indicating the page has been updated in the history timeline. This reflects a refresh of the study record without changing the underlying study data.SummaryDifference0.1%

- Check69 days agoChange DetectedAn added revision label shows Revision: v3.6.2 in the page footer, replacing Revision: v3.6.0. This indicates a software version update for the record history page.SummaryDifference0.1%

- Check83 days agoChange DetectedRecruitment status updated to show that no more participants are being sought. A new revision tag v3.6.0 has been added, replacing the previous v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.